STATEMENT/POSlTION - Vyripharm is in favor of Bill 3785

Houston, Tx., July 29, 2015

VYRIPRARM BIOPHARMACEUTICALS
Vyripharm is a biopharmaceutical firm focused on natural products, regulatory testing, pharmaceutical drug development, data storage, monitoring technology, development of imaging agents, and drug delivery systems. The aim of Vyripharm is to improve clinical management through diagnosis and treatment with, botanicals, synthetic pharmaceuticals, and drug delivery systems.

HOW CANNABIS WORKS IN THE BODY
Cannabis was extensively used as a medicine throughout the developed world in the nineteenth century but went into decline early in the twentieth century ahead of its emergence as the most widely used illicit recreational drug later that century. Recent advances in cannabinoid pharmacology alongside the discovery of the endocannabinoid system (ECS) have re-ignited interest in cannabis-based medicines. The ECS has emerged as an important physiological system and plausible target for new medicines. Its receptors and endogenous ligands play a vital modulatory role in diverse functions including immune response, food intake, cognition, emotion, perception, behavioral reinforcement, motor co-ordination, body temperature, wake/ sleep cycle, bone formation and resorption, and various aspects of hormonal control (Robson J., Therapeutic potential o/Cannabinoid Medicines, 2014).

WHAT DOES THE SCIENCE SAY ABOUT MEDICAL MARIJUANA
There is a mountain of scientific evidence that demonstrates marijuana is a safe and effective medicine for people suffering from a variety of debilitating medical conditions. Why would hundreds of thousands of seriously ill people risk being arrested and possibly imprisoned to use something that doesn't work? In 1999, the National Academy of Sciences' Institute of Medicine (TOM) reported, "Nausea, appetite loss, pain, and anxiety are aU afflictions of wasting, and aU can be mitigated by marijuana (MPP, 2014).

WHAT WOULD BE THE EFFECTS JF THIS BILL PASSED
Doctors would be able to recommend the use of medical marijuana. Clinicians who treat the disorders listed in HB3785 would be able to recommend marijuana as a treatment of: cancer, HIV I AIDs, irritable bowel syndrome, Alzheimer's disease, PTSD, multiple sclerosis, chronic neuropathy pain, epilepsy, and other defined conditions.